Director, Finance Gross-to-Net Reporting - Job ID : DFGR

Director, Finance Gross-to-Net (Gtn) Reporting

Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology.

Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.

Guided by our core values of Patients, Science, and Passion, we use our TransCon drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.

Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to grow and develop their skills.

Position Summary

The Director, Finance Gross-to-Net (GTN) Reporting will lead the development, execution, and oversight of government pricing and GTN analytics & reporting across the U.S. business. This individual will serve as a strategic partner to Finance, Market Access, Analytics & Commercial Operations and other US teams, ensuring compliance with evolving federal and state pricing regulations while maximizing net revenue and supporting business planning and decision-making. This role requires a deep understanding of U.S. government pricing programs, GTN forecasting and analytics, and the pharmaceutical reimbursement landscape.